Table 3 Genotypes of deafness pedigrees

From: Comprehensive genetic testing of Chinese SNHL patients and variants interpretation using ACMG guidelines and ethnically matched normal controls

Family

Inheritance patterns

Genes

Gene accession numbers

Nucleotide changes

Amino acid changes

No. of patientsa

No. of Normal hearing family membersa

1

AD

EYA4

NM_004100.4 NP_004091.3

c.1364delG

p.(Gly455a)

3

1

2

AD

GSDME

NG_011593.1

NM_004403.2

NP_004394.1

c. 991-1G>C

Splicing site

3

3

3

AD

TMC1

NM_138691.2 NP_619636.2

c.1714G>A

p.(Asp572Asn)

3

3

4

AD

ACTG1

NM_001614.4 NP_001605.1

c.638A>G

p.(Lys213Arg)

5

2

5

AD

EYA4

NM_004100.4

NP_004091.3

c.544insA

p.(Phe221a)

7

8

6

AD

KCNQ4

NM_004700.3 NP_004691.2

c.887G>A

p.(Gly296Ala)

4

2

7

AD

POU4F3

NM_002700.2

NP_002691.1

c.602T>C

p.(Leu201Pro)

2

1

8

AR

MYO7A

NM_000260.3 NP_000251.3

c.[73G>A]; [462C>A]

p.(Gly25Arg); (Cys154a)

3

4

9

AR

TMPRSS3

NM_024022.2 NP_076927.1

c.[916G>A]; [36delC]

c.[916G>A]; [316C>T]

p.(Ala306Thr); (Phe13Serfs12)

p.(Ala306Thr); (Arg106Cys)

2

2

10

AR

TECTA

NM_005422.2 NP_005413.2

c.[257C>G]; [260_262delTTC]

p.(Ser86Cys); (Pro88del)

4

8

11

AR

CDH23

NM_022124.5 NP_071407.4

c.[6220delC]; [1117G>A]

p.(Leu2074a); (Val373Met)

2

2

12

AR

SLC26A4

NG_008489.1

NM_000441.1

NP_000432.1

c.[919-2A>G]; [1226G>A]

Splicing site; p.(Arg409His)

2

2

13

AR

SLC26A4

NG_008489.1

NM_000441.1

NP_000432.1

c.[1614-6T>G];

[1240_1243delinsGAGA>AAAG]

Splicing site; p.(Glu414_Ser415delinsLysGly)

2

2

14

AR

SLC26A4

NM_000441.1 NP_000432.1

c.[1226G>A]; [1340delA]

p.(Arg409His); (Lys447Serfs*8)

2

2

15

AR

MYO7A

NM_000260.3 NP_000251.3

c.[1991C>T]; [3799G>A]

p.(Thr664Ile); (Gly1267Arg)

2

0

16

X-linked

POU3F4

NM_000307.4 NP_000298.3

c.973delT

p.(Trp325Glyfs*12)

2

4

17

X-linked

POU3F4

NM_000307.4 NP_000298.3

c.927_929delCTC

p.(Ser310del)

4

11

  1. aNumber of patients or normal hearing family members who were tested by DA1 or/and DA3 panel. The DA1 or DA3 (Otogenetics Corporation, Atlanta, GA) panel includes targeted capture of 43 deafness genes and 119 deafness genes, respectively. For the list of 119 genes please see Table S1. Family 11–16 were tested by DA1 primitively and when DA3 came out, they were tested again as positive samples. The results either by DA1 or by DA3 are consistent